Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Contents

Current Pharmaceutical Design, Volume 15 - Number 14




Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders

, 15(14): 1595 - 1611

Rodrigo Machado-Vieira, Giacomo Salvadore, Lobna A. Ibrahim, Nancy Diaz-Granados and Carlos A. Zarate Jr.


DOI: 10.2174/138161209788168010


Opiates as Antidepressants

, 15(14): 1612 - 1622

Esther Berrocoso, Pilar Sanchez-Blazquez, Javier Garzon and Juan A. Mico


DOI: 10.2174/138161209788168100









Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog